Company news

PureTech Health PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

PRTC: New IPF Data Show Switch Patients Stabilized

September 29, 2025

Pdmr dealing - purchase of shares

September 24, 2025

PureTech Founded Entity Seaport Therapeutics Advances Second Therapeutic Candidate into Clinical Development with Dosing of First Participant in Phase 1 Study of GlyphAgo™ (SPT-320) in Healthy Volunteers

September 11, 2025

PRTC's Seaport Advances 2nd Candidate Into Clinic

September 11, 2025

PureTech Health plc – Half-Year Report

August 28, 2025

Half-year Report

August 28, 2025

PureTech Showcases Differentiated IPF Strategy

August 21, 2025

PureTech Showcases Differentiated Development Strategy, Including New Patient Preference Insights, and Spotlights Phase 2b Data Positioning Deupirfenidone as a Potential New Standard of Care in IPF

August 21, 2025

PureTech Health: Notice of Half-Yearly Results

August 18, 2025

Notice of Results

August 18, 2025

PureTech Founded Entity Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint

August 13, 2025

PRTC's Vedanta Announces VE202 Phase 2 Results

August 13, 2025

PureTech Announces the Launch of Celea Therapeutics With a Mission to Transform the Treatment of Respiratory Diseases

August 12, 2025

PRTC Launches Celea to Advance Ph3-Ready IPF Drug

August 12, 2025

PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo™ (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress

July 17, 2025

PRTC’s Seaport Begins Phase 2b Study in MDD

July 17, 2025

PureTech Announces Leadership Transition

July 16, 2025

PureTech Announces Board Change

July 8, 2025

Directorate Change

July 8, 2025

PDMR Notification

July 4, 2025

PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement

June 26, 2025

PRTC'S Vor Announces RemeGen License & $175M PIPE

June 26, 2025

PureTech Health: Results of Annual General Meeting

June 16, 2025

Result of AGM

June 16, 2025

PureTech to Present at the Jefferies Global Healthcare Conference

May 22, 2025

PRTC to Present at Jefferies Healthcare Conference

May 22, 2025

PRTC: IPF Data Support Lung Function Stabilization

May 21, 2025

PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial

May 20, 2025

PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF)

May 9, 2025

PRTC Publishes Research on Unmet IPF Patient Needs

May 9, 2025

PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference

May 1, 2025

PRTC To Present Ph2b IPF Results at ATS Conference

May 1, 2025

PureTech Announces Annual Results for Year Ended December 31, 2024

April 30, 2025

Final Results

April 30, 2025

PureTech Health: Notice of Results

April 23, 2025

PureTech Appoints Peel Hunt as Joint UK Corporate Broker

April 9, 2025

PRTC Appoints Peel Hunt Joint UK Corporate Broker

April 9, 2025

Rule 2.8 Announcement

April 7, 2025

PureTech Health plc Statement Regarding Press Speculation

April 7, 2025

Statement re Possible Offer

April 7, 2025

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

March 11, 2025

PRTC's Seaport Adds Finance/Operations Exec to BOD

March 11, 2025

PureTech to Present at the Leerink Partners Global Healthcare Conference

February 25, 2025

PRTC Presents at Leerink Partners Healthcare Conf

February 25, 2025

PRTC's Seaport Publishes New Glyph Platform Data

February 12, 2025

PRTC's Vedanta Publishes Ph2 in Nature Medicine

January 27, 2025

PRTC's LYT-200 Gets Fast Track Designation in AML

January 9, 2025

PureTech Appoints UBS as UK Corporate Broker

January 6, 2025

PRTC's Ph2b in IPF Successful; New SOC Potential

December 16, 2024

PRTC's Seaport Presents Ph1 SPT-300 Data at ACNP

December 11, 2024

← Newer news releases · Older news releases →

Calls

The 5 newest of 6 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.